From Computational Genomics
Dr. Hodor's current work focuses on developing next generation computational tools for genomics, using big data technologies. He has a long-standing interest in deriving knowledge from data in the life sciences, applying diverse methods drawn from machine learning, statistics, and bioinformatics. Recent work at Booz Allen includes support for federal government projects at the Food and Drug Administration, the National Institutes of Health, and Centers for Medicare & Medicaid Services. Previously, Dr. Hodor was a bioinformatics scientist at Cellumen, Inc., and Merck & Co., Inc., where he applied high content screening and microarray technologies to augment pharmaceutical basic research projects. Dr. Hodor holds a Ph.D. in Biological Sciences from Carnegie Mellon University.